Publication:
Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008-2020.

Loading...
Thumbnail Image

Date

2021-03-05

Authors

Ventura, Celia
Gomes, Bruno Costa
Oberemm, Axel
Louro, Henriqueta
Huuskonen, Pasi
Mustieles, Vicente
Fernández, Mariana F
Ndaw, Sophie
Mengelers, Marcel
Luijten, Mirjam

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Academic Press
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

A number of human biomonitoring (HBM) studies have presented data on exposure to hexavalent chromium [Cr(VI)] and cadmium (Cd), but comparatively few include results on effect biomarkers. The latter are needed to identify associations between exposure and adverse outcomes (AOs) in order to assess public health implications. To support improved derivation of EU regulation and policy making, it is of great importance to identify the most reliable effect biomarkers for these heavy metals that can be used in HBM studies. In the framework of the Human Biomonitoring for Europe (HBM4EU) initiative, our study aim was to identify effect biomarkers linking Cr(VI) and Cd exposure to selected AOs including cancer, immunotoxicity, oxidative stress, and omics/epigenetics. A comprehensive PubMed search identified recent HBM studies, in which effect biomarkers were examined. Validity and applicability of the markers in HBM studies are discussed. The most frequently analysed effect biomarkers regarding Cr(VI) exposure and its association with cancer were those indicating oxidative stress (e.g., 8-hydroxy-2'-deoxyguanosine (8-OHdG), malondialdehyde (MDA), glutathione (GSH)) and DNA or chromosomal damage (comet and micronucleus assays). With respect to Cd and to some extent Cr, β-2-microglobulin (B2-MG) and N-acetyl-β-D-glucosaminidase (NAG) are well-established, sensitive, and the most common effect biomarkers to relate Cd or Cr exposure to renal tubular dysfunction. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule (KIM)-1 could serve as sensitive biomarkers of acute kidney injury in response to both metals, but need further investigation in HBM studies. Omics-based biomarkers, i.e., changes in the (epi-)genome, transcriptome, proteome, and metabolome associated with Cr and/or Cd exposure, are promising effect biomarkers, but more HBM data are needed to confirm their significance. The combination of established effect markers and omics biomarkers may represent the strongest approach, especially if based on knowledge of mechanistic principles. To this aim, also mechanistic data were collected to provide guidance on the use of more sensitive and specific effect biomarkers. This also led to the identification of knowledge gaps relevant to the direction of future research.

Description

MeSH Terms

Biological Monitoring
Biomarkers
Cadmium
Chromium
Europe
Humans

DeCS Terms

Biomarcadores
Cadmio
Cromo
Europa (Continente)
Humanos
Monitoreo biológico

CIE Terms

Keywords

Adverse outcome pathway (AOP), Cancer, Immunotoxicity, Mode of action, Nephrotoxicity, Oxidative stress, Toxic metals

Citation

Ventura C, Gomes BC, Oberemm A, Louro H, Huuskonen P, Mustieles V, et al. Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008-2020. Environ Res. 2021 Jun;197:110998.